Honeysoy - it is my understanding that specialist versions of the 1A for early identification of maternal hypertension are on the design table as part of the new upgraded manufacturing and distribution process. This may even mean renaming and targeted sales material.
UCM have developed a high class web presentation structure for their sales material and you will note on doing a google for "spirosonic" that they are moving towards focused promotion on individual products for individual markets.
I did forget to mention that sales in USA have been improving partly offset by slower sales in parts of Europe including Hungary which got a real hammering with Covid - but that is passed and things are improving again.
The BP+ has been completely redesigned - there were weaknesses in some of the purchased-in internal components - these have been replaced with superior products. I expect the BP+ will find a ready market.
Cheers to all
- Forums
- ASX - By Stock
- Ann: Consolidation of less than marketable parcels
Honeysoy - it is my understanding that specialist versions of...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UCM (ASX) to my watchlist
|
|||||
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.241M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 47229 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 24486 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 47229 | 0.013 |
3 | 994992 | 0.012 |
1 | 300099 | 0.010 |
1 | 100000 | 0.009 |
1 | 120000 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 24486 | 1 |
0.022 | 51903 | 2 |
0.030 | 10083 | 1 |
0.035 | 32196 | 1 |
0.050 | 42345 | 1 |
Last trade - 16.12pm 14/08/2024 (20 minute delay) ? |
Featured News
UCM (ASX) Chart |
Day chart unavailable